Prolonged infusion of gemcitabine in advanced solid tumors: A phase-I-study.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 139, doi. 10.1007/s10637-005-5859-4
- By:
- Publication type:
- Article
Works matching IS 01676997 AND DT 2005 AND VI 23 AND IP 2
Results: 11
1
2
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: A phase II trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 171, doi. 10.1007/s10637-005-5863-8
- By:
- Publication type:
- Article
3
Phase II trial of fenretinide in advanced renal carcinoma.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 179, doi. 10.1007/s10637-005-5864-7
- By:
- Publication type:
- Article
4
Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel™.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 121, doi. 10.1007/s10637-005-5856-7
- By:
- Publication type:
- Article
5
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 99, doi. 10.1007/s10637-005-5854-9
- By:
- Publication type:
- Article
6
Resveratrol regulates cellular PKC α and δ to inhibit growth and induce apoptosis in gastric cancer cells.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 111, doi. 10.1007/s10637-005-5855-8
- By:
- Publication type:
- Article
7
Transient respiratory failure possibly associated to imatinib.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 137, doi. 10.1007/s10637-005-5858-5
- By:
- Publication type:
- Article
8
A phase II trial of ZD1839 (Iressa™) 750 mg per day, an oral epidermal growth factor receptor-tyrosine kinase inhibitor, in patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 165, doi. 10.1007/s10637-005-5862-9
- By:
- Publication type:
- Article
9
Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 157, doi. 10.1007/s10637-005-5861-x
- By:
- Publication type:
- Article
10
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 147, doi. 10.1007/s10637-005-5860-y
- By:
- Publication type:
- Article
11
A phase I and pharmacokinetic study of VNP40101M, a new alkylating agent, in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 2, p. 123, doi. 10.1007/s10637-005-5857-6
- By:
- Publication type:
- Article